Apollo Hospitals Acquires Remaining Stake in Apollo Gleneagles PET-CT

Apollo Hospitals Enterprise Limited (AHEL), one of India’s leading healthcare providers, has completed the acquisition of the remaining 50% stake in Apollo Gleneagles PET-CT Private Limited (AGPCL) from Parkway Healthcare (Mauritius) Pte Ltd. This marks a significant strategic step for the company as AGPCL now becomes a wholly-owned subsidiary of Apollo Hospitals.

The acquisition involved the purchase of 85,00,000 equity shares with a face value of ₹10 each, representing 50% of AGPCL’s total paid-up equity share capital. The transaction, which had been approved by the board of directors in August 2025, was successfully concluded on October 3, 2025.

Strengthening Apollo’s Diagnostic Capabilities

With full ownership of AGPCL, Apollo Hospitals is expected to enhance its diagnostic imaging and cancer screening services. PET-CT (Positron Emission Tomography–Computed Tomography) plays a crucial role in oncology and advanced medical imaging, aiding in early detection and effective treatment planning.

This acquisition aligns with Apollo’s broader vision of expanding its diagnostic and precision medicine network across India. By integrating AGPCL fully into its operations, Apollo aims to strengthen synergies in clinical excellence, technology, and patient care outcomes.

Strategic Move for Long-Term Growth

The complete ownership of AGPCL is also seen as part of Apollo Hospitals’ strategy to consolidate its partnerships and streamline management control over key subsidiaries. This move will likely help in faster decision-making, innovation in diagnostic services, and stronger financial performance in the long term.

Also Read: Apollo Hospitals to Double AI Investment Over the Next 2 to 3 Yrs!

Apollo Hospitals Enterprise Share Price Performance

On October 3, 2025, Apollo Hospitals share price (NSE: APOLLOHOSP) opened at ₹7,441.00 and closed at ₹7,450.00, up by 0.12%. The stock price touched its day’s high at ₹7,484.00.

Conclusion

By acquiring Parkway Healthcare’s stake in Apollo Gleneagles PET-CT, Apollo Hospitals has reinforced its commitment to expanding its healthcare ecosystem and diagnostic excellence, ensuring comprehensive, technology-driven patient care.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.